BridgeBio Pharma, Inc. 13D and 13G filings for EIDOS THERAPEUTICS INC:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-01-26 09:00 am Sale | 2021-01-26 | 13D | EIDOS THERAPEUTICS INC EIDX | BridgeBio Pharma Inc. BBIO | 1,000 100.000% | -24,574,501 (-100.00%) | Filing |
| 2020-10-05 5:30 pm Unchanged | 2020-10-05 | 13D | EIDOS THERAPEUTICS INC EIDX | BridgeBio Pharma Inc. BBIO | 24,575,501 63.700% | 0 (Unchanged) | Filing |